For the third time in four years, CNBC has ranked North Carolina as “America’s Top State for Business” in 2025.

Verona Pharma, a year after receiving regulatory approval for its landmark chronic obstructive pulmonary disease (COPD) treatment, is being acquired by pharmaceutical giant Merck in a deal worth about ...

Establishing strong international partnerships starts with clear expectations and well-structured agreements. Join EDPNC on July 16 for a 90-minute strategy session covering building productive and ...

Durham-based GeneCentric Therapeutics, a cancer diagnostics company, has closed on an $8 million round of venture capital to launch and commercialize a novel liquid biopsy platform for guiding ...

NCBiotech is working with statewide partners to drive strategy and support the CRO sector. By working together to expand the clinical-based workforce and awareness of the CRO community, North Carolina ...

The North Carolina Biotechnology Center is a life science economic development organization that helps bring ideas to market, grows North Carolina's cluster of life science companies to meet industry ...

This session is organized by GLOBE – Global Life Sciences Opportunities Business Exchange, an Intellectual Exchange Group with the North Carolina Biotechnology Center. GLOBE partners include the U.S.

Join NCLifeSci on July 17 for a panel discussion covering the state of laboratory and specialty space across the country and in NC. Panelists will discuss the design of laboratory spaces needed to ...

Hosted by BTEC Why should you attend? Attend this course to gain a fundamental understanding of successful bioanalytical assay development and validation. This course is composed of primarily hands-on ...

This event will feature a presentation by PharmaBioServ CEO Victor Sanchez and networking opportunities. The North Carolina Bio Pharma Networking Group, launched in 2017, connects communities across ...

Serving twice as commissioner of the U.S. Food and Drug Administration has made Robert Califf, M.D., pretty much immune to getting tripped up by difficult or controversial questions. “People should ...